![Jennifer Chao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 162 667 $ in data 31/05/2026
Jennifer M.
Chao is the founder of Corestrategies Management LLC, founded in 2008, where the title held is Managing Partner.
Current jobs include Independent Director at Endo International Plc since 2021, Independent Director at Cardiol Therapeutics, Inc. since 2022, and Director at Endo Pharmaceuticals, Inc. Former jobs include Chairman at BioSpecifics Technologies Corp.
from 2019 to 2020, Managing Director at RBC Capital Markets, Inc. from 2002 to 2004, Independent Director at Edesa Biotech, Inc. from 2022 to 2023, Director at Protagenic Therapeutics, Inc. in 2025, Research Analyst at Deutsche Bank Securities, Inc., and Vice President at Leerink Swann & Co. from 2001 to 2002.
Education includes an undergraduate degree from New York University conferred in 1992.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/12/2025 | 133.334 ( 0,12% ) | 162 667 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENDO INTERNATIONAL PLC | Direttore/Membro del Consiglio | 17/02/2021 |
| CARDIOL THERAPEUTICS INC. | Direttore/Membro del Consiglio | 15/03/2022 |
Corestrategies Management LLC | Fondatore | 01/01/2008 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 03/11/2025 |
| EDESA BIOTECH, INC. | Direttore/Membro del Consiglio | 01/06/2023 |
| BIOSPECIFICS TECHNOLOGIES CORP. | Presidente | 02/12/2020 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 29/02/2008 |
RBC Capital Markets, Inc.
 RBC Capital Markets, Inc. Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01/03/2004 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications | Health Technology |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Provides investment advice | Finance |
Leerink Swann & Co.
 Leerink Swann & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Protagenic Therapeutics, Inc.
 Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
Cardiol Therapeutics, Inc.
 Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease | Health Technology |
Edesa Biotech, Inc.
 Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Corestrategies Management LLC |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
